(Total Views: 540)
Posted On: 07/03/2018 6:58:09 AM
Post# of 110
OncBioMune has received all necessary approvals from the host hospital, associated committees and the U.S. Food and Drug Administration to begin the Phase 2 trial. All requisite information has been submitted to clinicaltrials.gov, with the expectations that the summary of the trial will soon be available for public viewing.
https://www.otcmarkets.com/stock/OBMP/news/On...?id=197023
https://www.otcmarkets.com/stock/OBMP/news/On...?id=197023
(0)
(0)Scroll down for more posts ▼
